Report overview
Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Umbilical Cord Blood, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Umbilical Cord Blood. This report contains market size and forecasts of Stem Cell Umbilical Cord Blood in global, including the following market information:
Global Stem Cell Umbilical Cord Blood Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Stem Cell Umbilical Cord Blood market was valued at US$ 19570 million in 2022 and is projected to reach US$ 120630 million by 2029, at a CAGR of 29.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
We surveyed the Stem Cell Umbilical Cord Blood companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Umbilical Cord Blood Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Umbilical Cord Blood Market Segment Percentages, by Type, 2022 (%)
Public Cord Blood Banks
Private Cord Blood Banks
Global Stem Cell Umbilical Cord Blood Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Stem Cell Umbilical Cord Blood Market Segment Percentages, by Application, 2022 (%)
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome
Global Stem Cell Umbilical Cord Blood Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Stem Cell Umbilical Cord Blood Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Umbilical Cord Blood revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Stem Cell Umbilical Cord Blood revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Stem Cell Umbilical Cord Blood, market overview.
Chapter 2: Global Stem Cell Umbilical Cord Blood market size in revenue.
Chapter 3: Detailed analysis of Stem Cell Umbilical Cord Blood company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Stem Cell Umbilical Cord Blood in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
